Women in the developing world want the ability to space births, but have limited access to long-lasting reversible contraceptive implants. Limited competition, fragmented procurement, high upfront costs and a shortage of trained workers prevented the market from reaching its potential.
Contraceptive implants offer developing world women a valuable option for long-acting but reversible contraception. The 2012 Family Planning Summit committed to giving 120m women access to family planning information, contraceptives and services. Providing product savings of 50%+ will free up capital to streamline procurement practices, service delivery and other market infrastructure, making more product available.
Bayer HealthCare AG, Manufacturer of Jadelle
Co-guarantors: Norway, CIFF, SIDA
Procurers: USAID, DfID, UNFPA
Foundation focus: Increasing developing country access to a wider range of affordable contraceptive methods
Volume guaranty: price reduction
Date: January 2013
Associated funding: donor consortium to provide supporting investments in service delivery, implementation and monitoring